Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Brain gray matter alterations have been reported in cross-sectional magnetic resonance imaging (MRI) studies of breast cancer patients after cancer treatment. Here we report the first prospective MRI study of women undergoing treatment for breast cancer, with or without chemotherapy, as well as healthy controls. We hypothesized that chemotherapy-associated changes in gray matter density would be detectable 1 month after treatment, with partial recovery 1 year later. Participants included breast cancer patients treated with (CTx+, N = 17) or without (CTx−, N = 12) chemotherapy and matched healthy controls (N = 18). MRI scans were acquired at baseline (after surgery but before radiation, chemotherapy, and/or anti-estrogen treatment), 1 month after completion of chemotherapy (M1), and 1 year later (Y1). Voxel-based morphometry (VBM) was used to evaluate gray matter density differences between groups and over time. There were no between-group gray matter differences at baseline. Group-by-time interactions showed declines from baseline to M1 in both cancer groups relative to controls. Within-group analyses indicated that at M1 relative to baseline the CTx+ group had decreased gray matter density in bilateral frontal, temporal, and cerebellar regions and right thalamus. Recovery was seen at Y1 in some regions, although persistent decreases were also apparent. No significant within-group changes were found in the CTx− or control groups. Findings were not attributable to recency of cancer surgery, disease stage, psychiatric symptoms, psychotropic medication use, or hormonal treatment status. This study is the first to use a prospective, longitudinal approach to document decreased brain gray matter density shortly after breast cancer chemotherapy and its course of recovery over time. These gray matter alterations appear primarily related to the effects of chemotherapy, rather than solely reflecting host factors, the cancer disease process, or effects of other cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · cited 1×
“VBM methods [4, 5, 13] using SPM (Version 5, Wellcome Department of Imaging Neuroscience, London, UK), similar to our prior studies [27, 29, 39].”
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Spielberger, C. D. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0943 · Cited by 2,535
Cerebellum and nonmotor function
Strick, P. L., Dum, R. P., & Fiez, J. A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125606 · Cited by 1,777 · cited 1×
“Cerebellar regions are also increasingly recognized as important in higher cognitive functions [34].”
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Self-citationWhy Voxel-based morphometry should be used
Ashburner, J., & Friston, K. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0961 · Cited by 842
A demographically based index of premorbid intelligence for the WAIS--R.
Barona, A., Reynolds, C. R., & Chastain, R. (1984) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.52.5.885 · Cited by 619
Sydeman, S. (2020) · Encyclopedia of Personality and Individual Differences · doi:10.1007/978-3-319-24612-3_950 · Cited by 606
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI
Saykin, A. J., Wishart, H. A., Rabin, L. A., Santulli, R. B., Flashman, L. A., West, J. D., McHugh, T. L., & Mamourian, A. C. (2006) · Neurology · doi:10.1212/01.wnl.0000234032.77541.a2 · Cited by 585
Self-citationBaseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort
Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929273 · Cited by 538
Self-citationSilverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., et al. (2007) · Cancer · doi:10.1002/cncr.22368 · Cited by 350
Cognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345
Self-citation‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm500 · Cited by 331
Self-citationANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8639 · Cited by 272
Self-citationSchilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Huizenga, H. M., Nortier, J. W., van de Velde, C. J., van Dam, F. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3553 · Cited by 269
Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006) · The Clinical Neuropsychologist · doi:10.1080/138540491005875 · Cited by 225
Estrogen- and tamoxifen-associated effects on brain structure and function
Eberling, J. L., Wu, C., Tong-Turnbeaugh, R., & Jagust, W. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.08.037 · Cited by 213
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/s1084-3612(03)00055-8 · Cited by 194
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
Quesnel, C., Savard, J., & Ivers, H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0114-2 · Cited by 182
A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa
Castro-Fornieles, J., Bargalló, N., Lázaro, L., Andrés, S., Falcon, C., Plana, M. T., & Junqué, C. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.013 · Cited by 177
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009) · Psycho-Oncology · doi:10.1002/pon.1379 · Cited by 168
Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele
Wishart, H. A., Saykin, A. J., McAllister, T. W., Rabin, L. A., McDonald, B. C., Flashman, L. A., Roth, R. M., Mamourian, A. C., Tsongalis, G. J., & Rhodes, C. H. (2006) · Neurology · doi:10.1212/01.wnl.0000238079.00472.3a · Cited by 159
Self-citationYamada, T. H., Denburg, N. L., Beglinger, L. J., & Schultz, S. K. (2010) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22.1.48 · Cited by 137
Cognitive functioning in breast cancer survivors: A controlled comparison
Jim, H. S. L., Donovan, K. A., Small, B. J., Andrykowski, M. A., Munster, P. N., & Jacobsen, P. B. (2009) · Cancer · doi:10.1002/cncr.24192 · Cited by 128
Monkul, E. S., Matsuo, K., Nicoletti, M., Dierschke, N. A., Hatch, J. P., Dalwani, M. S., Brambilla, P., Caetano, S. C., Sassi, R. B., Mallinger, A. G., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.074 · Cited by 126
Neurocognitive Changes in Cancer Survivors
Correa, D. D., & Ahles, T. A. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31818d8769 · Cited by 124
Self-citationJenkins, V. A., Ambroisine, L. M., Atkins, L., Cuzick, J., Howell, A., & Fallowfield, L. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70207-9 · Cited by 120
Weis, J., Poppelreuter, M., & Bartsch, H. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1472 · Cited by 112
Hermelink, K., Henschel, V., Untch, M., Bauerfeind, I., Lux, M. P., & Münzel, K. (2008) · Cancer · doi:10.1002/cncr.23853 · Cited by 96
Mild cognitive impairment: Conceptual issues and structural and functional brain correlates
Saykin, A. J., & Wishart, H. A. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50002 · Cited by 95
Self-citationPalmer, J. L., Trotter, T., Joy, A. A., & Carlson, L. E. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0070-1 · Cited by 89 · cited 1×
“Anti-estrogen (hormonal) therapies have shown detrimental cognitive effects distinct from chemotherapy in some studies [7, 9, 24, 30], although not others [15, 17].”
Yasuda, C. L., Valise, C., Saúde, A. V., Pereira, A. R., Pereira, F., Costa, A. L. F., Morita, M. E., Betting, L. E., Castellano, G., Guerreiro, C. A. M., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.08.014 · Cited by 86
Hakamata, Y., Matsuoka, Y., Inagaki, M., Nagamine, M., Hara, E., Imoto, S., Murakami, K., Kim, Y., & Uchitomi, Y. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.012 · Cited by 82
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390801992725 · Cited by 75
Yoshikawa, E., Matsuoka, Y., Yamasue, H., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., Fujimori, M., Nakaya, N., Akizuki, N., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.018 · Cited by 45
Li, C.-Q., Liu, D., Huang, L., Wang, H., Zhang, J.-Y., & Luo, X. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.07.010 · Cited by 40
Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat
Koros, C., Papalexi, E., Anastasopoulos, D., Kittas, C. N., & Kitraki, E. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.016 · Cited by 32
Brain imaging investigation of chemotherapy-induced neurocognitive changes
McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545900.004 · Cited by 11
Self-citation
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationPrevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Self-citationCancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Self-citationKoppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0189 · Cited by 556
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0827 · Cited by 535
Self-citation
Metadata
- Authors
- McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2010-08-06
- Volume
- 123
- Issue
- 3
- Pages
- 819-828
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2022559601
- Cited by
- 331
- References
- 44
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.